##gff-version 3
##sequence-region P42224 1 750
P42224	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:22223895;Dbxref=PMID:22223895	
P42224	UniProtKB	Chain	2	750	.	.	.	ID=PRO_0000182410;Note=Signal transducer and activator of transcription 1-alpha/beta	
P42224	UniProtKB	Domain	573	670	.	.	.	Note=SH2;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00191	
P42224	UniProtKB	Coiled coil	136	317	.	.	.	Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9630226;Dbxref=PMID:9630226	
P42224	UniProtKB	Modified residue	2	2	.	.	.	Note=N-acetylserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:22223895;Dbxref=PMID:22223895	
P42224	UniProtKB	Modified residue	114	114	.	.	.	Note=N6-methyllysine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28753426;Dbxref=PMID:28753426	
P42224	UniProtKB	Modified residue	175	175	.	.	.	Note=N6-methyllysine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28753426;Dbxref=PMID:28753426	
P42224	UniProtKB	Modified residue	296	296	.	.	.	Note=N6-methyllysine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28753426;Dbxref=PMID:28753426	
P42224	UniProtKB	Modified residue	366	366	.	.	.	Note=N6-methyllysine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28753426;Dbxref=PMID:28753426	
P42224	UniProtKB	Modified residue	525	525	.	.	.	Note=N6-methyllysine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28753426;Dbxref=PMID:28753426	
P42224	UniProtKB	Modified residue	637	637	.	.	.	Note=N6-methyllysine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28753426;Dbxref=PMID:28753426	
P42224	UniProtKB	Modified residue	657	657	.	.	.	Note=ADP-ribosyl glutamic acid%3B by PARP14;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27796300;Dbxref=PMID:27796300	
P42224	UniProtKB	Modified residue	665	665	.	.	.	Note=N6-methyllysine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28753426;Dbxref=PMID:28753426	
P42224	UniProtKB	Modified residue	701	701	.	.	.	Note=Phosphotyrosine%3B by JAK1%2C JAK2 or TYK2;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17561467,ECO:0000269|PubMed:19088846,ECO:0000269|PubMed:21135090,ECO:0000269|PubMed:22065572,ECO:0000269|PubMed:26479788,ECO:0000269|PubMed:27796300,ECO:0000269|PubMed:28753426,ECO:0000269|PubMed:7657660;Dbxref=PMID:17561467,PMID:19088846,PMID:21135090,PMID:22065572,PMID:26479788,PMID:27796300,PMID:28753426,PMID:7657660	
P42224	UniProtKB	Modified residue	705	705	.	.	.	Note=ADP-ribosyl glutamic acid%3B by PARP14;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27796300;Dbxref=PMID:27796300	
P42224	UniProtKB	Modified residue	708	708	.	.	.	Note=Phosphoserine%3B by IKKE;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22065572;Dbxref=PMID:22065572	
P42224	UniProtKB	Modified residue	727	727	.	.	.	Note=Phosphoserine%3B by MAPK14;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:18691976,ECO:0000244|PubMed:19690332,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:23186163,ECO:0000269|PubMed:15322115,ECO:0000269|PubMed:17897103,ECO:0000269|PubMed:21135090,ECO:0000269|PubMed:22065572,ECO:0000269|PubMed:26479788,ECO:0000269|PubMed:7543024;Dbxref=PMID:18669648,PMID:18691976,PMID:19690332,PMID:20068231,PMID:23186163,PMID:15322115,PMID:17897103,PMID:21135090,PMID:22065572,PMID:26479788,PMID:7543024	
P42224	UniProtKB	Modified residue	745	745	.	.	.	Note=Phosphoserine%3B by IKKE;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:P42225	
P42224	UniProtKB	Cross-link	703	703	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1)%3B alternate;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:25114211;Dbxref=PMID:25114211	
P42224	UniProtKB	Cross-link	703	703	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)%3B alternate;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
P42224	UniProtKB	Alternative sequence	713	750	.	.	.	ID=VSP_006282;Note=In isoform Beta. Missing;Ontology_term=ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:15489334,ECO:0000303|Ref.6;Dbxref=PMID:15489334	
P42224	UniProtKB	Natural variant	30	30	.	.	.	ID=VAR_034521;Note=I->T;Dbxref=dbSNP:rs34255470	
P42224	UniProtKB	Natural variant	165	165	.	.	.	ID=VAR_065934;Note=In IMD31C%3B gain of function mutation associated with increased STAT1 phosphorylation due to impaired nuclear dephosphorylation. D->G;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:21727188,ECO:0000269|PubMed:23709754;Dbxref=dbSNP:rs387906764,PMID:21727188,PMID:23709754	
P42224	UniProtKB	Natural variant	165	165	.	.	.	ID=VAR_065935;Note=In IMD31C. D->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21727188;Dbxref=dbSNP:rs387906767,PMID:21727188	
P42224	UniProtKB	Natural variant	170	170	.	.	.	ID=VAR_065936;Note=In IMD31C. Y->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21727188;Dbxref=dbSNP:rs387906766,PMID:21727188	
P42224	UniProtKB	Natural variant	174	174	.	.	.	ID=VAR_065937;Note=In IMD31C. C->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21727188;Dbxref=dbSNP:rs387906763,PMID:21727188	
P42224	UniProtKB	Natural variant	179	179	.	.	.	ID=VAR_075494;Note=In IMD31C%3B gain of function%3B increases transactivation activity in response to IFNG. N->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23709754;Dbxref=dbSNP:rs587777628,PMID:23709754	
P42224	UniProtKB	Natural variant	201	201	.	.	.	ID=VAR_065815;Note=In IMD31B%3B not deleterious in terms of most STAT1 functions%3B causes abnormal splicing out of exon 8 from most mRNAs thereby decreasing protein levels by approximately 70%25. K->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20841510;Dbxref=dbSNP:rs587776870,PMID:20841510	
P42224	UniProtKB	Natural variant	202	202	.	.	.	ID=VAR_065938;Note=In IMD31C. M->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21727188;Dbxref=PMID:21727188	
P42224	UniProtKB	Natural variant	202	202	.	.	.	ID=VAR_065939;Note=In IMD31C. M->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21727188;Dbxref=dbSNP:rs387906762,PMID:21727188	
P42224	UniProtKB	Natural variant	267	267	.	.	.	ID=VAR_065940;Note=In IMD31C. A->V;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:21714643,ECO:0000269|PubMed:21727188;Dbxref=dbSNP:rs387906759,PMID:21714643,PMID:21727188	
P42224	UniProtKB	Natural variant	271	271	.	.	.	ID=VAR_065941;Note=In IMD31C. Q->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21727188;Dbxref=dbSNP:rs387906768,PMID:21727188	
P42224	UniProtKB	Natural variant	274	274	.	.	.	ID=VAR_065942;Note=In IMD31C%3B gain of function%3B increases STAT1 phosphorylation due to impaired nuclear dephosphorylation%3B increases transactivation activity in response to IFNG. R->Q;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:21727188,ECO:0000269|PubMed:23709754;Dbxref=dbSNP:rs387906760,PMID:21727188,PMID:23709754	
P42224	UniProtKB	Natural variant	274	274	.	.	.	ID=VAR_065943;Note=In IMD31C%3B gain of function%3B increases phosphorylation in response to IFNG%2C IFNA and IL27 due to a loss of dephosphorylation. R->W;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:21714643,ECO:0000269|PubMed:21727188,ECO:0000269|PubMed:23709754;Dbxref=dbSNP:rs387906758,PMID:21714643,PMID:21727188,PMID:23709754	
P42224	UniProtKB	Natural variant	278	278	.	.	.	ID=VAR_075495;Note=In IMD31C%3B gain of function%3B increases phosphorylation in response to IFNG and IFNA due to a loss of dephosphorylation. K->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25288569;Dbxref=dbSNP:rs863223398,PMID:25288569	
P42224	UniProtKB	Natural variant	285	285	.	.	.	ID=VAR_075496;Note=In IMD31C%3B gain of function%3B increases transactivation activity in response to IFNG. Q->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23709754;Dbxref=dbSNP:rs587777629,PMID:23709754	
P42224	UniProtKB	Natural variant	286	286	.	.	.	ID=VAR_065944;Note=In IMD31C. K->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21727188;Dbxref=dbSNP:rs387906761,PMID:21727188	
P42224	UniProtKB	Natural variant	288	288	.	.	.	ID=VAR_065945;Note=In IMD31C. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21727188;Dbxref=dbSNP:rs387906765,PMID:21727188	
P42224	UniProtKB	Natural variant	298	298	.	.	.	ID=VAR_075497;Note=In IMD31C%3B gain of function%3B increases basal STAT1 phosphorylation levels which are 10-20 fold higher than controls after IFNG stimulation. K->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26514428;Dbxref=PMID:26514428	
P42224	UniProtKB	Natural variant	320	320	.	.	.	ID=VAR_065816;Note=In IMD31A%3B affects the DNA-binding activity of the protein. E->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16934001;Dbxref=dbSNP:rs137852680,PMID:16934001	
P42224	UniProtKB	Natural variant	384	384	.	.	.	ID=VAR_075498;Note=In IMD31C%3B gain of function%3B increases phosphorylation in response to IFNG and IFNA due to a loss of dephosphorylation. G->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25288569;Dbxref=dbSNP:rs796065052,PMID:25288569	
P42224	UniProtKB	Natural variant	385	385	.	.	.	ID=VAR_075499;Note=In IMD31C%3B gain of function%3B increases phosphorylation in response to IFNG%2C IFNA and IL27 due to a loss of dephosphorylation. T->M;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:23709754,ECO:0000269|PubMed:25288569;Dbxref=dbSNP:rs587777630,PMID:23709754,PMID:25288569	
P42224	UniProtKB	Natural variant	463	463	.	.	.	ID=VAR_065817;Note=In IMD31A%3B affects the DNA-binding activity of the protein. Q->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16934001;Dbxref=dbSNP:rs137852679,PMID:16934001	
P42224	UniProtKB	Natural variant	491	491	.	.	.	ID=VAR_036001;Note=In a breast cancer sample%3B somatic mutation. P->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16959974;Dbxref=PMID:16959974	
P42224	UniProtKB	Natural variant	600	600	.	.	.	ID=VAR_018265;Note=In IMD31B%3B found in an infant who died of a viral-like illness associated with complete STAT1 deficiency. L->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12590259;Dbxref=dbSNP:rs137852678,PMID:12590259	
P42224	UniProtKB	Natural variant	637	637	.	.	.	ID=VAR_068713;Note=In IMD31A%3B affects both phosphorylation and DNA-binding activity%3B results in impaired STAT1-mediated cellular response to IFN-gamma and interleukin-27. K->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22573496;Dbxref=dbSNP:rs587777705,PMID:22573496	
P42224	UniProtKB	Natural variant	673	673	.	.	.	ID=VAR_068714;Note=In IMD31A%3B impairs tyrosine phosphorylation%3B results in impaired STAT1-mediated cellular response to IFN-gamma and interleukin-27. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22573496;Dbxref=dbSNP:rs587777704,PMID:22573496	
P42224	UniProtKB	Natural variant	701	701	.	.	.	ID=VAR_075500;Note=In IMD31B%3B disrupts transactivation activity in response to IFNG. Y->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23709754;Dbxref=PMID:23709754	
P42224	UniProtKB	Natural variant	706	706	.	.	.	ID=VAR_018266;Note=In IMD31A%3B loss of GAF and ISGF3 activation%3B impairs the nuclear accumulation of GAF but not of ISGF3 in heterozygous cells stimulated by IFNs%3B affects phosphorylation of the protein. L->S;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11452125,ECO:0000269|PubMed:16934001;Dbxref=dbSNP:rs137852677,PMID:11452125,PMID:16934001	
P42224	UniProtKB	Mutagenesis	110	110	.	.	.	Note=Sumoylated. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12764129;Dbxref=PMID:12764129	
P42224	UniProtKB	Mutagenesis	114	114	.	.	.	Note=No effect on IFN-alpha-induced STAT1 phosphorylation and nuclear translocation. K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28753426;Dbxref=PMID:28753426	
P42224	UniProtKB	Mutagenesis	175	175	.	.	.	Note=No effect on IFN-alpha-induced STAT1 phosphorylation and nuclear translocation. K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28753426;Dbxref=PMID:28753426	
P42224	UniProtKB	Mutagenesis	296	296	.	.	.	Note=No effect on IFN-alpha-induced STAT1 phosphorylation and nuclear translocation. K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28753426;Dbxref=PMID:28753426	
P42224	UniProtKB	Mutagenesis	366	366	.	.	.	Note=No effect on IFN-alpha-induced STAT1 phosphorylation and nuclear translocation. K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28753426;Dbxref=PMID:28753426	
P42224	UniProtKB	Mutagenesis	525	525	.	.	.	Note=Strongly reduced IFN-alpha-induced STAT1 phosphorylation and nuclear translocation. Does not affect ability to homodimerize. K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28753426;Dbxref=PMID:28753426	
P42224	UniProtKB	Mutagenesis	636	637	.	.	.	Note=No effect on IFN-alpha-induced STAT1 phosphorylation and nuclear translocation. KK->AA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28753426;Dbxref=PMID:28753426	
P42224	UniProtKB	Mutagenesis	656	658	.	.	.	Note=Enhances STAT1 nuclear translocation and interferon (IFN)-stimulated gene (ISG) expression in response to IFN-beta stimulation. Reduces viral load in infected cultured cells. AEN->CEC;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26479788;Dbxref=PMID:26479788	
P42224	UniProtKB	Mutagenesis	657	657	.	.	.	Note=Loss of ADP-ribosylation and increased Tyr-701 phosphorylation%3B when associated with Q-705. E->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27796300;Dbxref=PMID:27796300	
P42224	UniProtKB	Mutagenesis	665	665	.	.	.	Note=No effect on IFN-alpha-induced STAT1 phosphorylation and nuclear translocation. K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:28753426;Dbxref=PMID:28753426	
P42224	UniProtKB	Mutagenesis	701	701	.	.	.	Note=Not phosphorylated at S-708 upon IFNB induction. Y->E;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17897103,ECO:0000269|PubMed:22065572;Dbxref=PMID:17897103,PMID:22065572	
P42224	UniProtKB	Mutagenesis	701	701	.	.	.	Note=No effect on basal sumoylation. Enhances sumoylation in the presence of MAPK stimulation. Phosphorylated at S-708 upon IFNB induction. Y->F;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17897103,ECO:0000269|PubMed:22065572;Dbxref=PMID:17897103,PMID:22065572	
P42224	UniProtKB	Mutagenesis	703	703	.	.	.	Note=Abolishes sumoylation by SUMO1. Increased IFN-gamma-mediated transactivation. K->R;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12764129,ECO:0000269|PubMed:12855578;Dbxref=PMID:12764129,PMID:12855578	
P42224	UniProtKB	Mutagenesis	705	705	.	.	.	Note=Loss of ADP-ribosylation and increased Tyr-701 phosphorylation%3B when associated with Q-657. E->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27796300;Dbxref=PMID:27796300	
P42224	UniProtKB	Mutagenesis	708	708	.	.	.	Note=Phosphorylated at Y-701 upon IFNB induction. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22065572;Dbxref=PMID:22065572	
P42224	UniProtKB	Mutagenesis	708	708	.	.	.	Note=Not phosphorylated at Y-701 upon IFNB induction. S->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22065572;Dbxref=PMID:22065572	
P42224	UniProtKB	Mutagenesis	727	727	.	.	.	Note=Decreased transcriptional activation. No effect on basal sumoylation. No enhancement of sumoylation on MAPK stimulation. No PRKCD-induced apoptosis. Upon IFNB induction%2C phosphorylated at Y-701 but not at S-708. S->A;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15322115,ECO:0000269|PubMed:17897103,ECO:0000269|PubMed:22065572;Dbxref=PMID:15322115,PMID:17897103,PMID:22065572	
P42224	UniProtKB	Mutagenesis	727	727	.	.	.	Note=No change in enhancement of MAPK-induced sumoylation. Basal interaction with PIAS1. Interaction with PIAS1 increased on MAPK stimulation. S->D;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15322115,ECO:0000269|PubMed:17897103,ECO:0000269|PubMed:22065572;Dbxref=PMID:15322115,PMID:17897103,PMID:22065572	
P42224	UniProtKB	Mutagenesis	727	727	.	.	.	Note=No change in enhancement of MAPK-induced sumoylation. S->E;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15322115,ECO:0000269|PubMed:17897103,ECO:0000269|PubMed:22065572;Dbxref=PMID:15322115,PMID:17897103,PMID:22065572	
P42224	UniProtKB	Sequence conflict	46	46	.	.	.	Note=A->T;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P42224	UniProtKB	Sequence conflict	307	307	.	.	.	Note=S->G;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P42224	UniProtKB	Sequence conflict	718	718	.	.	.	Note=Q->R;Ontology_term=ECO:0000305;evidence=ECO:0000305	
P42224	UniProtKB	Helix	3	7	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3WWT	
P42224	UniProtKB	Helix	12	21	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3WWT	
P42224	UniProtKB	Beta strand	23	26	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3WWT	
P42224	UniProtKB	Helix	28	33	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3WWT	
P42224	UniProtKB	Helix	35	40	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3WWT	
P42224	UniProtKB	Helix	43	46	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3WWT	
P42224	UniProtKB	Helix	50	73	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3WWT	
P42224	UniProtKB	Helix	77	94	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3WWT	
P42224	UniProtKB	Helix	99	120	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:3WWT	
P42224	UniProtKB	Helix	121	125	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1YVL	
P42224	UniProtKB	Helix	137	179	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1BF5	
P42224	UniProtKB	Helix	189	192	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1YVL	
P42224	UniProtKB	Helix	193	195	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1YVL	
P42224	UniProtKB	Helix	198	247	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1BF5	
P42224	UniProtKB	Helix	257	286	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1BF5	
P42224	UniProtKB	Helix	293	316	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1BF5	
P42224	UniProtKB	Beta strand	317	321	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1BF5	
P42224	UniProtKB	Beta strand	334	336	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1BF5	
P42224	UniProtKB	Beta strand	339	347	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1BF5	
P42224	UniProtKB	Helix	352	354	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1BF5	
P42224	UniProtKB	Turn	355	357	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1BF5	
P42224	UniProtKB	Beta strand	359	365	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1BF5	
P42224	UniProtKB	Helix	370	373	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1BF5	
P42224	UniProtKB	Beta strand	374	376	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1BF5	
P42224	UniProtKB	Beta strand	380	382	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1YVL	
P42224	UniProtKB	Beta strand	386	389	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1BF5	
P42224	UniProtKB	Beta strand	391	395	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1BF5	
P42224	UniProtKB	Turn	396	398	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1BF5	
P42224	UniProtKB	Beta strand	399	408	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1BF5	
P42224	UniProtKB	Beta strand	421	425	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1BF5	
P42224	UniProtKB	Beta strand	433	441	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1BF5	
P42224	UniProtKB	Beta strand	444	451	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1BF5	
P42224	UniProtKB	Beta strand	455	460	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1BF5	
P42224	UniProtKB	Helix	461	463	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1BF5	
P42224	UniProtKB	Helix	464	477	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1BF5	
P42224	UniProtKB	Helix	486	488	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1BF5	
P42224	UniProtKB	Helix	495	509	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1BF5	
P42224	UniProtKB	Helix	516	526	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1BF5	
P42224	UniProtKB	Helix	539	543	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1BF5	
P42224	UniProtKB	Beta strand	550	552	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1BF5	
P42224	UniProtKB	Helix	554	568	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1BF5	
P42224	UniProtKB	Helix	570	574	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1BF5	
P42224	UniProtKB	Helix	584	590	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1BF5	
P42224	UniProtKB	Turn	591	593	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1BF5	
P42224	UniProtKB	Beta strand	601	603	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1BF5	
P42224	UniProtKB	Beta strand	612	616	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1BF5	
P42224	UniProtKB	Beta strand	621	624	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1BF5	
P42224	UniProtKB	Beta strand	627	631	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1YVL	
P42224	UniProtKB	Helix	636	640	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1BF5	
P42224	UniProtKB	Helix	644	649	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1BF5	
P42224	UniProtKB	Beta strand	657	659	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1BF5	
P42224	UniProtKB	Helix	673	677	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1BF5	
P42224	UniProtKB	Turn	678	680	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1BF5	
P42224	UniProtKB	Helix	728	738	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2KA6	
P42224	UniProtKB	Turn	739	742	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2KA6	
P42224	UniProtKB	Helix	743	745	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2KA6	
P42224	UniProtKB	Turn	746	748	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2KA6	
